Bought
Maintained
Sold
Other funds holding LUMO
TAM
WSA
UBS's LUMO Position: Q3 2014 in Review
UBS reduced its Lumos Pharma (LUMO) stake by 26% in Q3 2014, selling an estimated $38.7K and leaving 500 shares worth $97K. The position accounts for ﹤0.01% of the portfolio, ranked #6039.
UBS first reported a position in LUMO in Q2 2013 and has held it in 6 quarters since. The position peaked at $250K in Q4 2013. 92 funds tracked by Wall St. Rank hold LUMO as of Q3 2014.
- UBS held 500 shares of Lumos Pharma worth $97K as of Q3 2014.
- UBS sold 176 Lumos Pharma shares in Q3 2014, an estimated $38.7K.
- Lumos Pharma made up ﹤0.01% of UBS's portfolio in Q3 2014, its #6039 holding.
- UBS first reported a position in Lumos Pharma in Q2 2013 and has held it in 6 quarters since.
- UBS's Lumos Pharma position peaked at $250K in Q4 2013.
- 92 funds tracked by Wall St. Rank held Lumos Pharma as of Q3 2014.
Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.